February 20, 2026

Allergen Sensitization in Skin of Color

Scoping review links contact allergy to AD severity

Conexiant

February 19, 2026

Afro-Textured Hair: Clinical Framework for Care

Investigators examine clinician communication, updated hair classification, and culturally informed care in Afro-textured hair.

Conexiant

February 18, 2026

Combo Therapy for Psoriasis With Obesity

A phase 3b trial tests ixekizumab plus tirzepatide in adults with moderate-to-severe plaque psoriasis and obesity or overweight.

Conexiant

February 13, 2026

Does Air Pollution Affect Skin Health?

Large systematic review finds consistent associations across conditions but highlights low certainty driven by bias and study heterogeneity.

Conexiant

February 13, 2026

Primary Care’s Rug Pulled Out?

CMS abruptly scraps a 10-year primary care model, leaving nearly 700 practices rethinking staffing, funding, and patient access.

KFF Health News

February 10, 2026

When Obesity Meets Infection Risk

Researchers analyze data from Finnish cohorts and the UK Biobank to examine how body mass index relates to severe infections and their global burden.

Conexiant

February 09, 2026

Dupilumab and Lymphoma Risk in AD?

Dupilumab is safe from a lymphoma-risk perspective in atopic dermatitis and other type 2 inflammatory diseases, based on real-world data.

Conexiant

February 05, 2026

Oral TYK2 Inhibition in Atopic Dermatitis

Phase 2 trial evaluated once-daily oral TYK2 inhibition in adults with moderate to severe AD.

Conexiant

February 04, 2026

Unexpected Finds After Routine Procedures

Two patients presented months after minimally invasive facial procedures with persistent findings that ultimately revealed retained foreign bodies, according to a recent case series.

Conexiant